Search for: "Barr Laboratories Inc "
Results 121 - 140
of 166
Sorted by Relevance
|
Sort by Date
1 Mar 2011, 8:38 pm
Roche Molecular Systems, Inc. [read post]
12 Feb 2009, 10:42 am
Barr Laboratories, Inc., 812 F. [read post]
18 Feb 2010, 10:34 am
Most notably there’s Mylan Laboratories, Inc. v. [read post]
30 Sep 2011, 2:32 pm
Barr Laboratories, Inc., 386 F.3d 485, 485 (2d Cir. 2004) [read post]
6 Jul 2009, 4:54 pm
., and a generic manufacturer, Barr Laboratories, Inc., along with Barr’s business partners who challenged Bayer, leading to the “reverse payments” deal. [read post]
20 Aug 2010, 6:27 am
Barr Laboratories, Inc. 437 F.3d 1181, 1195 (Fed. [read post]
12 Jun 2009, 10:49 am
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition of respondents Barr Laboratories, Inc. [read post]
12 Jul 2020, 9:06 pm
See the following press releases for complete details on the recalled products: Fresh Express Hy-Vee Inc. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
27 Aug 2011, 7:55 pm
Barr Labs., Inc., 575 F.3d 1341, 1350 (Fed. [read post]
25 Mar 2011, 8:29 pm
Barr Labs., Inc., 251 F.3d 955, 962 (Fed. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
7 Mar 2011, 12:02 pm
., Inc., v. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly (EPLAW) Indian… [read post]
29 Apr 2011, 1:03 pm
Barr Labs., Inc., 251 F.3d 955, 963 (Fed. [read post]
28 Oct 2011, 7:38 pm
Petitioners’ reply Amicus brief of International Municipal Lawyers Association Barr Laboratories, Inc. v. [read post]
28 Jun 2011, 5:03 pm
Barr Labs., 40 F.3d 1223, 1228 (Fed. [read post]
23 Aug 2007, 8:06 am
Barr Laboratories, Inc., 397 F. [read post]
